Navigation Links
USP Publishes Spanish Edition of United States Pharmacopeia and National Formulary
Date:1/29/2008

Eliminates the Need for Translation of Compendia Used to Ensure the Quality of Pharmaceutical and Over-the-Counter Medications

ROCKVILLE, Md., Jan. 29 /PRNewswire-USNewswire/ -- The U.S. Pharmacopeia is pleased to announce that the third annual Spanish edition of its core compendia, the United States Pharmacopeia and National Formulary (USP-NF), is now available for purchase. The official edition for 2008, USP 31-NF 26, provides specifications needed to produce more than 4,000 quality pharmaceuticals, excipients, dietary supplements, biologics and other therapeutics.

USP-NF, recognized by U.S. federal law as the country's official compendia for drug standards, offers access to monographs defining the required standards for the identity, quality, purity, strength, labeling and packaging for pharmaceutical and over-the-counter medications, dietary supplements, and other health care products. These standards are enforceable by the U.S. Food and Drug Administration for drugs marketed in or exported to the United States, and are also recognized by governments and regulatory agencies throughout the world.

"USP is proud to offer a Spanish edition of the USP-NF for the third year in a row," said Darrell Abernethy, M.D., Ph.D., chief science officer of USP. "By translating the compendia, we hope to better meet the needs of our Spanish-speaking partners as we work together to advance USP's mission of providing good pharmaceutical care for all people, all over the world."

The Spanish edition is an official, expert translation of the USP-NF in English. Written in a universal, neutral Spanish, the translation process is supervised by USP's Spanish Advisory Panel -- a dedicated body of leading scientific experts from Spanish-speaking countries. USP offers expert scientific and technical support in Spanish during business hours that are convenient for Spanish-speaking customers.

USP-NF is used by quality assurance and quality con
'/>"/>

SOURCE U.S. Pharmacopeia
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. The New England Journal of Medicine Publishes EURIDIS/ADONIS Study Results Showing Dronedarone Maintained Sinus Rhythm in Patients With Atrial Fibrillation or Flutter With no Observed Pro-Arrhythmia
2. American College of Physicians publishes The Fenway Guide to LGBT Health
3. In Honor of Hispanic Heritage Month and Spanish Speakers Worldwide International Hyperhidrosis Society Publishes Important New Patient Booklet in Spanish
4. Multiple Sclerosis Association of America Publishes Booklet about Depression in Multiple Sclerosis
5. American College of Physicians publishes "Peripheral Arterial Disease"
6. Thomson Scientific Publishes Who Is Making The Biggest Splash? - a Quarterly Review of Scientific Literature on Drugs and Therapies From July - September 2007
7. Thomson Scientific Publishes its Third Quarter Issue of the Ones to Watch Reviewing the Most Promising Drugs in the Pharmaceutical Pipeline
8. The Endocrine Society Publishes White Paper Calling for Greater Minority Participation in Clinical Research
9. Springer publishes La Chirurgia degli Organi de Movimento
10. The Diabetes Educator publishes systematic reviews for diabetes management
11. Latin American adolescents are more likely to become infected with HIV than Spanish
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2008)...oducts, home to sodium, study says , , ...lenty of sodium -- commonly known as salt -- in fo...should know that lower-fat foods can have much mor...inding of a report published online Monday by Con... 37 common supermarket items and found large amoun...
(Date:12/2/2008)...eld biopharmaceutical company, today announced tha...nvestigational product candidate, HZT 501, met all... fixed-dose combination product containing ibuprof...gnificant reduction in the incidence of non-steroi...astrointestinal (gastric and/or duodenal) ulcers i...
(Date:12/2/2008)...roPhage, Inc., http://www.microphage.com , annou...e company,s Board of Directors. Taussig was presi...rch Center in Denver, the nation,s leading institu... to 2006. His medical specialty,is pediatric pul...ensively and am impressed with its progress,in de...
(Date:12/2/2008)...-- In the wake of the deaths of two persons in pub...ern of abuse and neglect of those who have psychia...ndividuals is calling on the incoming Obama admini...als to institute widespread, substantive reforms i...would include raising standards and regulatory exp...
Breaking Medicine News(10 mins):Health News:High Salt Levels Common in Many Foods 2Health News:Horizon Therapeutics announces 2 pivotal HZT-501 Phase 3 trials meet primary endpoints 2Health News:MicroPhage Selects Lynn Taussig, MD for Board of Directors 2Health News:Tragedies Underscore Crisis in U.S. Public Mental Health System: National Advocacy Organization Demands Reforms 2Health News:Tragedies Underscore Crisis in U.S. Public Mental Health System: National Advocacy Organization Demands Reforms 3
...ngh set up a task force to fill up the healthcare ... lab technicians. The recruitment not only fills /...unemployed. The move is based on the recommendati...onal Commission on Macroeconomics and Health, high...
...d the lives of two children in Mumbai and many mor...ed at various hospitals. // Health authorities sai...to treat those 90-odd people who are undergoing tr... to hospitals Wednesday, particularly in south Mum...
...proved that decrease in the fine particulate air p...pulation. This drop in mortality rates was specifi...ory disease, according to Dr. Francine Laden, from...lained in a statement. Several epidemiologic studi...
...higher in the opinion of parents’ when compared to...as new research has pointed out that Australian Fo...ed to all other types of football. // The Aussie ...ports injuries, the second place being occupied by...
Other Medicine News:
(Date:11/26/2008)...., Nov. 26 Children who...gnificantly increased risk of developing mental il... a Mayo Clinic study published this month in Pedi...emy of Pediatrics. , , The retrospective st...ith strabismus (misaligned eyes) and compared them...
(Date:11/25/2008)...ss can improve recovery , , Audio and Web V...le on the Mayo Clinic News Blog. Please see the bo...ROCHESTER, Minn., Nov. 25 /PRNewswire-USNewswire/ ...patients don,t think they,re having a stroke -- an...ir condition worsens. The findings appear in the c...
(Date:11/25/2008)...ISCO, Calif., Nov. 25 Proteolix, I... novel therapeutics that target,protein degradati...ay,announced that data from two ongoing Phase 2 c... will be presented at the upcoming 50th Annual Mee... Carfilzomib is the first in a new class,of spec...
(Date:11/25/2008)...rolled in Clinical Trial to Assess Survival of Pat...pies for Unresectable Hepatocellular Carcinoma , ...ight Sciences Oncology, Inc. (LSO) today announced...clinical trial of Light Infusion Therapy(TM) (Litx...ar carcinoma (HCC), also known as hepatoma or prim...
Breaking Medicine Technology:Eye Divergence in Children Triples Risk of Mental Illness 2Do You Know You're Having a Stroke? 2Do You Know You're Having a Stroke? 3Proteolix to Present Clinical and Preclinical Data at the 50th Annual Meeting of the American Society of Hematology 2Proteolix to Present Clinical and Preclinical Data at the 50th Annual Meeting of the American Society of Hematology 3Light Sciences Oncology Completes Patient Enrollment in Phase 3 Clinical Trial of Litx as a Treatment for Hepatocellular Carcinoma 2Light Sciences Oncology Completes Patient Enrollment in Phase 3 Clinical Trial of Litx as a Treatment for Hepatocellular Carcinoma 3Light Sciences Oncology Completes Patient Enrollment in Phase 3 Clinical Trial of Litx as a Treatment for Hepatocellular Carcinoma 4Micromet Added to NASDAQ Biotechnology Index 9384 1Micromet Added to NASDAQ Biotechnology Index 9384 2Micromet Added to NASDAQ Biotechnology Index 9384 3Micromet Added to NASDAQ Biotechnology Index 9384 4Fat Sensing Hormones Might Fight Obesity 30710 1Fat Sensing Hormones Might Fight Obesity 30710 2International workshop aims to boost public engagement work in developing countries 30707 1International workshop aims to boost public engagement work in developing countries 30707 2International workshop aims to boost public engagement work in developing countries 30707 3Rong Li Lab offers insight into adaptive ability of cells 6066 1Rong Li Lab offers insight into adaptive ability of cells 6066 2
...SBOURG, France and VANCOUVER, April 26, 2007,/PRNe.... , a global,specialty pharmaceutical and medical ...rom its European pivotal trial examining the,Vascu...ap(TM)"),will be presented today at a scientific f...fety and efficacy of the Vascular,Wrap(TM) for use...
...very promises to make retina, spinal cord and othe...TON, April 26, 2007 /PRNewswire/ -- Scientists at ...of Harvard Medical,School, have identified a key m...o the adult central nervous system. The,study foun... by,stem cells) has the ability to break down barr...
Other Medicine Technology:Two-year data for Angiotech's Vascular Wrap Paclitaxel-Eluting Mesh,to be Presented at European Vascular Symposium 2Two-year data for Angiotech's Vascular Wrap Paclitaxel-Eluting Mesh,to be Presented at European Vascular Symposium 3Two-year data for Angiotech's Vascular Wrap Paclitaxel-Eluting Mesh,to be Presented at European Vascular Symposium 4Two-year data for Angiotech's Vascular Wrap Paclitaxel-Eluting Mesh,to be Presented at European Vascular Symposium 5Two-year data for Angiotech's Vascular Wrap Paclitaxel-Eluting Mesh,to be Presented at European Vascular Symposium 6Two-year data for Angiotech's Vascular Wrap Paclitaxel-Eluting Mesh,to be Presented at European Vascular Symposium 7Schepens Scientists Identify Key to Integrating Transplanted Nerve,Cells Into Injured Tissue 2Schepens Scientists Identify Key to Integrating Transplanted Nerve,Cells Into Injured Tissue 3
...feature-packed projectors ideal for any practice. ...for longer life -- up to 2,000 hours under typical...tial cost with an incandescent illumination system.... And both provide exceptionally even illumination...
...cal design and utilizes a multi-layered, multi-coa... producing a measurable 20% increase in optical re...lity of the Ultra Series also results in a 20% inc...of view and a 14% increase in depth of field. A si...
With the touch of a button, the Marco Encore Automatic Chair quickly reclines from an upright position to a fully horizontal, flat-table mode-or anywhere in between.
Both the Marco Keratometer I and Keratometer II are one position instruments for objectively measuring corneal curvature. The keratometer II has the added feature of internal readings for the presbyo
Medicine Products: